Carbo-G
En vente sur le marché américain (selon le DSLD)
TransFormation Professional Protocol, food supplement from the US market
Carbo-G (TransFormation Professional Protocol), a food supplement au code-barres 632889400239, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- TransFormation Professional Protocol
- Barcode
- 632889400239
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- number of servings per day not stated
- Other ingredients (in English, as written)
- Hypromellose, Water
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Tzyme Enzyme Blend | Blend | 373 mg |
| Protease Blend | Enzyme | 205 mg |
| Phytase | Enzyme | not stated |
| Amylase | Enzyme | not stated |
| Alpha-Galactosidase | Enzyme | not stated |
| Glucoamylase | Enzyme | not stated |
| Pectinase | Enzyme | not stated |
| Lipase | Enzyme | not stated |
| Lactase | Enzyme | not stated |
| Protease 3.0 | Enzyme | not stated |
| Cellulase | Enzyme | not stated |
| Hemicellulase | Enzyme | not stated |
| Invertase | Enzyme | not stated |
| Diastase | Enzyme | not stated |
| Herbal Blend | Blend | 63 mg |
| Fennel | Plant | not stated |
| Ginger | Plant | not stated |
| Flaxseed (Linum usitatissimum) | Plant | not stated |
| Peppermint | Plant | not stated |
| Artichoke leaf extract | Plant | not stated |
| Bifidobacterium longum infantis | Micro-organism | 6 mg |
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Flaxseed
Read the warning, when it applies and the studies cited
FLAXSEED - LINUM USITATISSIMUM
Route of administration: Oral
Cautions and warnings
Applies to products providing 5 g or more of flaxseed per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Laxative; Promotion of bowel movement; Constipation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Applies to products providing 5 g or more of flaxseed per day.
Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : TransFormation Professional Protocol
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.